Short answer
Humacyte, Inc. (HUMA) filed an 8-K current report with the SEC on June 9, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders elected all three Class II directors, including Kathleen Sebelius, with terms extending to the 2029 annual meeting.
Humacyte, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders elected all three Class II directors, including Kathleen Sebelius, with terms extending to the 2029 annual meeting
- Executive compensation approved on an advisory basis, with 40.1M votes for versus 19.5M against
- Annual say-on-pay votes approved, establishing yearly advisory compensation votes until the next frequency vote
- PwC appointment ratified for fiscal 2026, receiving 125.2M votes for and no broker non-votes
- Authorized common shares increased from 350M to 550M, expanding potential financing capacity and dilution risk
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Humacyte, Inc. 8-K filings
Get the next HUMA 8-K as it lands
Follow HUMA for push alerts, or ask the research agent what this filing means.